These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16516684)

  • 1. Step-by-step lifestyle changes that can improve urologic health in men, part I: What do I tell my patients?
    Moyad MA
    Prim Care; 2006 Mar; 33(1):139-63, ix. PubMed ID: 16516684
    [No Abstract]   [Full Text] [Related]  

  • 2. Step-by-step lifestyle changes that can improve urologic health in men, part II: What do I tell my patients?
    Moyad MA
    Prim Care; 2006 Mar; 33(1):165-85, ix-x. PubMed ID: 16516685
    [No Abstract]   [Full Text] [Related]  

  • 3. Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?
    Moyad MA; Carroll PR
    Urol Clin North Am; 2004 May; 31(2):289-300. PubMed ID: 15123408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key developments in men's health.
    Kirby M
    Practitioner; 2000 Sep; 244(1614):728, 733-6. PubMed ID: 11048369
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of participants in a health promotion program for treated hypertensives (ADAPT).
    Burke V; Mansour J; Beilin LJ; Mori TA
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):198-206. PubMed ID: 17327140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    Bañez LL; Sun L; Trock BJ; Han M; Partin AW; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
    Loeb S; Yu X; Nadler RB; Roehl KA; Han M; Hawkins SA; Catalona WJ
    J Urol; 2007 Jan; 177(1):102-6; discussion 106. PubMed ID: 17162013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can men reduce the risk of prostate cancer through lifestyle changes?
    Colli J
    J Urol; 2009 Nov; 182(5):2101-2. PubMed ID: 19758645
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
    Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
    BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916.
    Montgomery RB; Goldman B; Tangen CM; Hussain M; Petrylak DP; Page S; Klein EA; Crawford ED;
    J Urol; 2007 Nov; 178(5):1946-51; discussion 1951. PubMed ID: 17868721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
    Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass screening-based case-control study of diet and prostate cancer in Changchun, China.
    Li XM; Li J; Tsuji I; Nakaya N; Nishino Y; Zhao XJ
    Asian J Androl; 2008 Jul; 10(4):551-60. PubMed ID: 18478158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiovascular prevention and lifestyle quiz for cardiologists.
    De Sutter J; Conraads VM
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S8-10. PubMed ID: 19675443
    [No Abstract]   [Full Text] [Related]  

  • 17. Cultural factors and patients' adherence to lifestyle measures.
    Serour M; Alqhenaei H; Al-Saqabi S; Mustafa AR; Ben-Nakhi A
    Br J Gen Pract; 2007 Apr; 57(537):291-5. PubMed ID: 17394732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype.
    Cho SW; Kang JY; Park YK; Paek YM; Choi TI
    Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should men over the age of 65 years receive PSA screening? Argument in favor.
    Whitson JM; Konety BR
    Nat Clin Pract Urol; 2008 May; 5(5):230-1. PubMed ID: 18349861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.